Potentiation of brain stimulation reward by morphine: Effects of neurokinin-1 receptor antagonism

Psychopharmacology

Volumn 220, Issue 1, 2012, Pages 215-224

  Robinson, J E ^a   Fish, E W ^a   Krouse, M C ^a   Thorsell, A ^b   Heilig, M ^b   Malanga, C J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Dopamine; Morphine; Neurokinin; Opioid; Reinforcement; Reward; Substance P

Indexed keywords

2 BENZHYDRYL 3 (2 IODOBENZYLAMINO)QUINUCLIDINE; 3 [3,5 BIS(TRIFLUOROMETHYL)BENZYLOXY] 2 PHENYLPIPERIDINE; L 703 606; L 733 060; MORPHINE SULFATE; NALTREXONE; PLACEBO; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; BRAIN REGION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; ELECTRODE; ELECTROSTIMULATION; HISTOLOGY; INTERMETHOD COMPARISON; LATERAL HYPOTHALAMUS; MALE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PARACRINE SIGNALING; PERCEPTIVE THRESHOLD; PRIORITY JOURNAL; REINFORCEMENT; REWARD; STIMULUS RESPONSE;

ANALGESICS, OPIOID; ANIMALS; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; MALE; MICE; MICE, INBRED C57BL; MORPHINE; NALTREXONE; NARCOTIC ANTAGONISTS; PIPERIDINES; QUINUCLIDINES; RECEPTORS, NEUROKININ-1; REINFORCEMENT (PSYCHOLOGY); REWARD; SUBSTANCE P;

EID: 84858440427     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2469-z     Document Type: Article

References (91)

1. Adams WJ, Lorens SA, Mitchell CL (1972) Morphine enhances lateral hypothalamic self-stimulation in the rat. Proc Soc Exp Biol Med 140:770-1
2. Bendani T, Cazala P (1988) Differential effects of intracerebral microinjection of morphine on approach and escape responses induced by lateral hypothalamic stimulation in the mouse. Pharmacol Biochem Behav 30:397-401 (Pubitemid 19264247)
3. Boix F, Sandor P, Nogueira PJ, Huston JP, Schwarting RK (1995) Relationship between dopamine release in nucleus accumbens and place preference induced by substance P injected into the nucleus basalis magnocellularis region. Neuroscience 64:1045-55
4. Bozarth MA, Wise RA (1986) Involvement of the ventral tegmental dopamine system in opioid and psychomotor stimulant reinforcement. NIDA Res Monogr 67:190-6 (Pubitemid 17193521)
5. Britt JP, McGehee DS (2008) Presynaptic opioid and nicotinic receptor modulation of dopamine overflow in the nucleus accumbens. J Neurosci 28:1672-81 (Pubitemid 351287040)
6. Carlezon WA Jr, Chartoff EH (2007) Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nat Protoc 2:2987-95
7. Carlezon WA Jr, Thomas MJ (2009) Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis. Neuro-pharmacology 56(Suppl 1):122-32
8. Cascieri MA, Ber E, Fong TM, Sadowski S, Bansal A, Swain C, Seward E, Frances B, Burns D, Strader CD (1992) Characterization of the binding of a potent, selective, radioiodinated antagonist to the human neurokinin-1 receptor. Mol Pharmacol 42:458-63 (Pubitemid 23024665)
9. Castellano C, Puglisi-Allegra S (1982) Effects of naloxone and naltrexone on locomotor activity in C57BL/6 and DBA/2 mice. Pharmacol Biochem Behav 16:561-3 (Pubitemid 12149769)
10. Cheer JF, Aragona BJ, Heien ML, Seipel AT, Carelli RM, Wightman RM (2007) Coordinated accumbal dopamine release and neural activity drive goal-directed behavior. Neuron 54:237-44 (Pubitemid 46561202)
11. Commons KG (2010) Neuronal pathways linking substance P to drug addiction and stress. Brain Res 1314:175-82
12. Cooper BR, Breese GR (1975) A role for dopamine in the psychopharmacology of electrical self-stimulation of the lateral hypothalamus, substantia nigra, and locus coeruleus. Psycho-pharmacol Bull 11:30-1
13. Criswell HE (1982) A simple methodology for opiate self-administration and electrical brain stimulation in the mouse. Life Sci 31:2391-4 (Pubitemid 13225571)
14. Cunningham CL, Niehus DR, Malott DH, Prather LK (1992) Genetic differences in the rewarding and activating effects of morphine and ethanol. Psychopharmacology (Berl) 107:385-93
15. De Felipe C, Herrero JF, O'Brien JA, Palmer JA, Doyle CA, Smith AJ, Laird JM, Belmonte C, Cervero F, Hunt SP (1998) Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature 392:394-7 (Pubitemid 28168736)
16. Di Chiara G, Imperato A (1988) Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther 244:1067-80 (Pubitemid 18090131)
17. Duffy RA, Varty GB, Morgan CA, Lachowicz JE (2002) Correlation of neurokinin (NK) 1 receptor occupancy in gerbil striatum with behavioral effects of NK1 antagonists. J Pharmacol Exp Ther 301:536-42 (Pubitemid 34429965)
18. Duvauchelle CL, Fleming SM, Kornetsky C (1996) Involvement of delta- and mu-opioid receptors in the potentiation of brain-stimulation reward. Eur J Pharmacol 316:137-43 (Pubitemid 27008143)
19. Elliott PJ, Alpert JE, Bannon MJ, Iversen SD (1986) Selective activation of mesolimbic and mesocortical dopamine metabolism in rat brain by infusion of a stable substance P analogue into the ventral tegmental area. Brain Res 363:145-7 (Pubitemid 16148029)
20. Elliott PJ, Mason GS, Stephens-Smith M, Hagan RM (1991) Behavioural and biochemical responses following activation of midbrain dopamine pathways by receptor selective neurokinin agonists. Neuropeptides 19:119-26
21. Elmer GI, Pieper JO, Goldberg SR, George FR (1995) Opioid operant self-administration, analgesia, stimulation and respiratory depression in mu-deficient mice. Psychopharmacology (Berl) 117:23-31
22. Elmer GI, Pieper JO, Hamilton LR, Wise RA (2010) Qualitative differences between C57BL/6J and DBA/2J mice in morphine potentiation of brain stimulation reward and intravenous self-administration. Psychopharmacology (Berl) 208:309-21
23. Esposito R, Kornetsky C (1977) Morphine lowering of self-stimulation thresholds: lack of tolerance with long-term administration. Science 195:189-91 (Pubitemid 8012001)
24. Esposito RU, McLean S, Kornetsky C (1979) Effects of morphine on intracranial self-stimulation to various brain stem loci. Brain Res 168:425-9 (Pubitemid 9176310)
25. Franklin KBJ, Paxinos G (2008) The Mouase Brain in Stereotaxic Coordinates, 3rd ed. Elsevier/Academic Press, Amsterdam; New York
26. Fish EW, Riday TT, McGuigan MM, Faccidomo S, Hodge CW, Malanga CJ (2010) Alcohol, cocaine, and brain stimulation-reward in C57Bl6/J and DBA2/J mice. Alcohol Clin Exp Res 34:81-9
27. Fong TM, Yu H, Strader CD (1992) Molecular basis for the species selectivity of the neurokinin-1 receptor antagonists CP-96,345 and RP67580. J Biol Chem 267:25668-71 (Pubitemid 23013958)
28. Frischknecht HR, Siegfried B, Riggio G, Waser PG (1983) Inhibition of morphine-induced analgesia and locomotor activity in strains of mice: a comparison of long-acting opiate antagonists. Pharmacol Biochem Behav 19:939-44 (Pubitemid 14209516)
29. Gadd CA, Murtra P, De Felipe C, Hunt SP (2003) Neurokinin-1 receptor-expressing neurons in the amygdala modulate morphine reward and anxiety behaviors in the mouse. J Neurosci 23:8271-80 (Pubitemid 37129644)
30. Galarraga E, Hernandez-Lopez S, Tapia D, Reyes A, Bargas J (1999) Action of substance P (neurokinin-1) receptor activation on rat neostriatal projection neurons. Synapse 33:26-35 (Pubitemid 29269947)
31. Goodman LS, Brunton LL, Chabner B, Knollmann BC (2011) Goodman & Gilman's the pharmacological basis of therapeutics, 12th edn. McGraw-Hill, New York
32. Harrigan SE, Downs DA (1978) Continuous intravenous naltrexone effects on morphine self-administration in rhesus monkeys. J Pharmacol Exp Ther 204:481-6 (Pubitemid 8290151)
33. Heilig M, Thorsell A, Sommer WH, Hansson AC, Ramchandani VA, George DT, Hommer D, Barr CS (2010) Translating the neuroscience of alcoholism into clinical treatments: from blocking the buzz to curing the blues. Neurosci Biobehav Rev 35:334-44
34. Holtzman SG (1976) Comparison of the effects of morphine, pentazocine, cyclazocine and amphetamine on intracranial self-stimulation in the rat. Psychopharmacologia 46:223-7
35. Izenwasser SE, Kornetsky C (1987) Pharmacological effects of morphine on brain-stimulation reward. Psychopharmacology (Berl) 93:136-7 (Pubitemid 17143741)
36. Jasmin L, Tien D, Weinshenker D, Palmiter RD, Green PG, Janni G, Ohara PT (2002) The NK1 receptor mediates both the hyper-algesia and the resistance to morphine in mice lacking noradrenaline. Proc Natl Acad Sci U S A 99:1029-34 (Pubitemid 34106630)
37. Jenck F, Gratton A, Wise RA (1987) Opioid receptor subtypes associated with ventral tegmental facilitation of lateral hypotha-lamic brain stimulation reward. Brain Res 423:34-8 (Pubitemid 17157151)
38. Johnson SW, North RA (1992) Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12:483-8
39. Kelley AE, Stinus L, Iversen SD (1979) Behavioural activation induced in the rat by substance P infusion into ventral tegmental area: implication of dopaminergic A10 neurones. Neurosci Lett 11:335-9 (Pubitemid 9130812)
40. Kenny PJ, Chen SA, Kitamura O, Markou A, Koob GF (2006) Conditioned withdrawal drives heroin consumption and decreases reward sensitivity. J Neurosci 26:5894-900 (Pubitemid 44318354)
41. Koob GF, Spector NH, Meyerhoff JL (1975) Effects of heroin on lever pressing for intracranial self-stimulation, food and water in the rat. Psychopharmacologia 42:231-4
42. Koob GF, Fray PJ, Iversen SD (1978) Self-stimulation at the lateral hypothalamus and locus coeruleus after specific unilateral lesions of the dopamine system. Brain Res 146:123-40 (Pubitemid 8316771)
43. Kornetsky C (1995) Action of opioid drugs on the brain-reward system. NIDA Res Monogr 147:33-52
44. Kornetsky C, Bain G (1992) Brain-stimulation reward: a model for the study of the rewarding effects of abused drugs. NIDA Res Monogr 124:73-93 (Pubitemid 23081975)
45. Korotkova TM, Brown RE, Sergeeva OA, Ponomarenko AA, Haas HL (2006) Effects of arousal- and feeding-related neuropeptides on dopaminergic and GABAergic neurons in the ventral tegmental area of the rat. Eur J Neurosci 23:2677-85 (Pubitemid 43801459)
46. Kraft M, Noailles P, Angulo JA (2001) Substance P modulates cocaine-evoked dopamine overflow in the striatum of the rat brain. Ann N Y Acad Sci 937:121-31 (Pubitemid 32613882)
47. Kuhr WG, Wightman RM, Rebec GV (1987) Dopaminergic neurons: simultaneous measurements of dopamine release and single-unit activity during stimulation of the medial forebrain bundle. Brain Res 418:122-8 (Pubitemid 17155590)
48. Lorens SA, Mitchell CL (1973) Influence of morphine on lateral hypothalamic self-stimulation in the rat. Psychopharmacologia 32:271-7
49. Malanga CJ, Riday TT, Carlezon WA, Jr., Kosofsky BE (2008) Prenatal exposure to cocaine increases the rewarding potency of cocaine and selective dopaminergic agonists in adult mice. Biol Psychiatry 63:214-21 (Pubitemid 350299312)
50. Marcus R, Kornetsky C (1974) Negative and positive intracranial reinforcement tresholds: effects of morphine. Psychopharmaco-logia (Berl) 38:1-13
51. Maurer R, Cortes R, Probst A, Palacios JM (1983) Multiple opiate receptor in human brain: an autoradiographic investigation. Life Sci 33(Suppl 1):231-4 (Pubitemid 14201072)
52. Substance Abuse and Mental Health Services Administration (2010) Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of national findings. In: Department of Health and Human Services (ed) (http://www.oas.samhsa.gov/NSDUH/2k9NSDUH/2k9Results.htm). Office of Applied Studies, Rockville, MD
53. Miliaressis E, Rompre PP, Laviolette P, Philippe L, Coulombe D (1986) The curve-shift paradigm in self-stimulation. Physiol Behav 37:85-91 (Pubitemid 16121802)
54. Mucha RF, van der Kooy D, O'Shaughnessy M, Bucenieks P (1982) Drug reinforcement studied by the use of place conditioning in rat. Brain Res 243:91-105 (Pubitemid 12082367)
55. Murphy NP, Lam HA, Maidment NT (2001) A comparison of morphine-induced locomotor activity and mesolimbic dopamine release in C57BL6, 129 Sv and DBA2 mice. J Neurochem 79:626-35 (Pubitemid 33029936)
56. Murtra P, Sheasby AM, Hunt SP, De Felipe C (2000) Rewarding effects of opiates are absent in mice lacking the receptor for substance P. Nature 405:180-3 (Pubitemid 30313535)
57. Olds ME (1979) Hypothalamic substrate for the positive reinforcing properties of morphine in the rat. Brain Res 168:351-60 (Pubitemid 9197858)
58. Olds J, Milner P (1954) Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J Comp Physiol Psychol 47:419-27
59. Oliverio A, Castellano C (1974) Genotype-dependent sensitivity and tolerance to morphine and heroin: dissociation between opiate-induced running and analgesia in the mouse. Psychopharmaco-logia 39:13-22
60. Olmstead MC, Burns LH (2005) Ultra-low-dose naltrexone suppresses rewarding effects of opiates and aversive effects of opiate withdrawal in rats. Psychopharmacology (Berl) 181:576-81 (Pubitemid 41480907)
61. Olmstead MC, Franklin KB (1997) The development of a conditioned place preference to morphine: effects of microinjections into various CNS sites. Behav Neurosci 111:1324-34 (Pubitemid 28010909)
62. Parker LA, Rennie M (1992) Naltrexone-induced aversions: assessment by place conditioning, taste reactivity, and taste avoidance paradigms. Pharmacol Biochem Behav 41:559-65
63. Phillips AG, Fibiger HC (1978) The role of dopamine in maintaining intracranial self-stimulation in the ventral tegmentum, nucleus accumbens, and medial prefrontal cortex. Can J Psychol 32:58-66
64. Phillips AG, LePiane FG (1980) Reinforcing effects of morphine microinjection into the ventral tegmental area. Pharmacol Bio-chem Behav 12:965-8 (Pubitemid 10039686)
65. Phillips AG, LePiane FG (1982) Reward produced by microinjection of (D-Ala2), Met5-enkephalinamide into the ventral tegmental area. Behav Brain Res 5:225-9 (Pubitemid 12085537)
66. Piepponen TP, Kivastik T, Katajamaki J, Zharkovsky A, Ahtee L (1997) Involvement of opioid mu 1 receptors in morphine-induced conditioned place preference in rats. Pharmacol Biochem Behav 58:275-9 (Pubitemid 27334383)
67. Quartara L, Altamura M, Evangelista S, Maggi CA (2009) Tachykinin receptor antagonists in clinical trials. Expert Opin Investig Drugs 18:1843-64
68. Ripley TL, Gadd CA, De Felipe C, Hunt SP, Stephens DN (2002) Lack of self-administration and behavioural sensitisation to morphine, but not cocaine, in mice lacking NK1 receptors. Neuropharmacology 43:1258-68 (Pubitemid 36084436)
69. Ross JW, Laska FJ, Fennessy MR (1978) Brain biogenic amines and intravenous self-administration of cocaine in rats. Clin Exp Pharmacol Physiol 5:351-9 (Pubitemid 9072720)
70. Rupniak NM, Jackson A (1994) Non-specific inhibition of dopamine receptor agonist-induced behaviour by the tachykinin NK1 receptor antagonist CP-99,994 in guinea-pigs. Eur J Pharmacol 262:171-5 (Pubitemid 24271851)
71. Rupniak NM, Carlson EC, Harrison T, Oates B, Seward E, Owen S, de Felipe C, Hunt S, Wheeldon A (2000) Pharmacological blockade or genetic deletion of substance P (NK(1)) receptors attenuates neonatal vocalisation in guinea-pigs and mice. Neuropharmacol-ogy 39:1413-21 (Pubitemid 30249203)
72. Rupniak NM, Carlson EJ, Webb JK, Harrison T, Porsolt RD, Roux S, de Felipe C, Hunt SP, Oates B, Wheeldon A (2001) Comparison of the phenotype of NK1R-/- mice with pharmacological blockade of the substance P (NK1) receptor in assays for antidepressant and anxiolytic drugs. Behav Pharmacol 12:497-508 (Pubitemid 33152274)
73. Schaefer GJ, Holtzman SG (1977) Dose- and time-dependent effects of narcotic analgesics on intracranial self-stimulation in the rat. Psychopharmacology (Berl) 53:227-34 (Pubitemid 8140299)
74. Schaefer GJ, Michael RP (1981) Threshold differences for naloxone and naltrexone in the hypothalamus and midbrain using fixed ratio brain self-stimulation in rats. Psychopharmacology (Berl) 74:17-22 (Pubitemid 11126454)
75. Seabrook GR, Shepheard SL, Williamson DJ, Tyrer P, Rigby M, Cascieri MA, Harrison T, Hargreaves RJ, Hill RG (1996) L-733,060, a novel tachykinin NK1 receptor antagonist; effects in [Ca2+]i mobilisation, cardiovascular and dural extravasation assays. Eur J Pharmacol 317:129-35 (Pubitemid 26427023)
76. Shippenberg TS, Heidbreder C, Lefevour A (1996) Sensitization to the conditioned rewarding effects of morphine: pharmacology and temporal characteristics. Eur J Pharmacol 299:33-9 (Pubitemid 26103434)
77. Shuster L, Webster GW, Yu G (1975a) Increased running response to morphine in morphine-pretreated mice. J Pharmacol Exp Ther 192:64-7
78. Shuster L, Webster GW, Yu G, Eleftheriou BE (1975b) A genetic analysis of the response to morphine in mice: analgesia and runnimg. Psychopharmacologia 42:249-54
79. Spanagel R, Herz A, Shippenberg TS (1990) The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J Neurochem 55:1734-40
80. Spyraki C, Fibiger HC, Phillips AG (1983) Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system. Psychopharmacology (Berl) 79:278-83 (Pubitemid 13192097)
81. Thorsell A, Schank JR, Singley E, Hunt SP, Heilig M (2010) Neurokinin-1 receptors (NK1R:s), alcohol consumption, and alcohol reward in mice. Psychopharmacology (Berl) 209:103-11
82. Todtenkopf MS, Marcus JF, Portoghese PS, Carlezon WA Jr (2004) Effects of kappa-opioid receptor ligands on intracra-nial self-stimulation in rats. Psychopharmacology (Berl) 172:463-70 (Pubitemid 38650984)
83. Trujillo KA, Belluzzi JD, Stein L (1989) Opiate antagonists and self-stimulation: extinction-like response patterns suggest selective reward deficit. Brain Res 492:15-28 (Pubitemid 19184533)
84. Valenstein ES, Campbell JF (1966) Medial forebrain bundle-lateral hypothalamic area and reinforcing brain stimulation. Am J Physiol 210:270-4
85. Warner M, Chen LH, Makuc DM (2009) Increase in fatal poisonings involving opioid analgesics in the United States, 1999-2006. NCHS Data Brief: 1-8.
86. West TE, Wise RA (1988) Effects of naltrexone on nucleus accumbens, lateral hypothalamic and ventral tegmental self-stimulation rate-frequency functions. Brain Res 462:126-33
87. Wilson MC, Hitomi M, Schuster CR (1971) Psychomotor stimulant self administration as a function of dosage per injection in the rhesus monkey. Psychopharmacologia 22:271-81
88. Wise RA (1989) Opiate reward: sites and substrates. Neurosci Biobehav Rev 13:129-33 (Pubitemid 19241927)
89. Wise RA (1998) Drug-activation of brain reward pathways. Drug Alcohol Depend 51:13-22 (Pubitemid 28353753)
90. Wise RA (2005) Forebrain substrates of reward and motivation. J Comp Neurol 493:115-21 (Pubitemid 41636193)
91. Yu YJ, Arttamangkul S, Evans CJ, Williams JT, von Zastrow M (2009) Neurokinin 1 receptors regulate morphine-induced endocytosis and desensitization of mu-opioid receptors in CNS neurons. J Neurosci 29:222-33